Randomized Sterile Compound Sample Testing
Priority 6 · one of 12 items in the Board of Pharmacy's request for 2028-29 · The item begins on page 65 of the request
This is a request, not an appropriation.
What is asked
| 2028 | 2029 | Two years | |
|---|---|---|---|
| All funds | $150,000 | $150,000 | $300,000 |
| Of which general revenue and general revenue-dedicated | $150,000 | $150,000 | $300,000 |
| Positions (full-time equivalents) | — | — |
How it would be financed
| Method of financing, as the request prints it | 2028 | 2029 |
|---|---|---|
| 1 General Revenue Fund | $150,000 | $150,000 |
| Total, as the request prints it | $150,000 | $150,000 |
Where it would land
The strategies this item would add to, numbered as the request numbers them, beside what each is appropriated in the current budget (2026-27 Act). One column is an appropriation and the other a request made on top of a base request not shown here, so the two are not subtracted.
| Strategy | Asked 2028 | Asked 2029 | Positions | Appropriated 2026 | Appropriated 2027 |
|---|---|---|---|---|---|
| 02-01-01 Operate System of Inspection Assistance EducationIn the current budget: B.1.1 ENFORCEMENT | $150,000 | $150,000 | — | $6,370,163 | $6,366,381 |
A strategy is matched by its name. Where none is matched, the strategy may be new, or may be in the current budget under a different name.
After 2029
| The agency's estimate | 2030 | 2031 | 2032 | Three years |
|---|---|---|---|---|
| All funds | $150,000 | $150,000 | $150,000 | $450,000 |
In the agency's words: Funding will need to be maintained.
The agency's justification
Funding would allow for sample testing of sterile compounded products obtained during agency inspections of pharmacies to check for sterility and endotoxins. Performing randomized testing of samples obtained during routine inspections would help ensure products compounded by pharmacies are safe for the public before the agency receives a complaint of harm or recall notice. Sterile compounding is a high-risk area of pharmacy practice, and without randomized testing the agency’s ability to check for safety is limited.
External and internal factors
External factors include enables an increased review of sterile compounding safety and compliance and increases the safety for the general public.
As marked in the request
- Has an information technology part: No
- Costs anticipated after the two budget years: Yes
- Involves contracts over $50,000: Yes